Bausch Health
327 hedge funds and large institutions have $1.96B invested in Bausch Health in 2017 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 107 increasing their positions, 89 reducing their positions, and 53 closing their positions.
26% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 53
20% more repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 89
4% more funds holding
Funds holding: 315 → 327 (+12)
7.48% less ownership
Funds ownership: 58.41% → 50.93% (-7.5%)
33% less capital invested
Capital invested by funds: $2.9B → $1.96B (-$948M)
38% less funds holding in top 10
Funds holding in top 10: 13 → 8 (-5)
39% less call options, than puts
Call options by funds: $190M | Put options by funds: $311M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JG
Jefferies Group
New York
|
+$71.8M |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$60.6M |
| 3 |
VH
ValueAct Holdings
San Francisco,
California
|
+$41.3M |
| 4 |
SAMH
Shanda Asset Management Holdings
Tortola,,
British Virgin Islands
|
+$31.6M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$30.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PSCM
Pershing Square Capital Management
New York
|
-$263M |
| 2 |
OFM
Okumus Fund Management
Grand Cayman,
Cayman Islands
|
-$59.5M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$56.2M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$54.2M |
| 5 |
Barclays
London,
United Kingdom
|
-$45.6M |
BHC Hedge Fund Activity: Q1 2017 in Review
327 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q1 2017, worth a combined $1.96B — down 33% from $2.9B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new BHC positions and 53 closed out — a net gain of 14 holders — while 107 added to existing stakes and 89 trimmed.
The largest buyer was Jefferies Group, adding an estimated $71.8M. The largest seller was Pershing Square Capital Management, exiting entirely with an estimated $263M sold.
- 327 institutional investors held Bausch Health (BHC) as of Q1 2017, up from 315 in Q4 2016.
- Funds reported $1.96B of Bausch Health stock for Q1 2017, down 33% quarter-over-quarter.
- 67 funds opened new Bausch Health positions in Q1 2017 and 53 closed out, a net change of +14 holders.
- The largest Bausch Health buyer in Q1 2017 was Jefferies Group, an estimated $71.8M added.
- The largest Bausch Health seller in Q1 2017 was Pershing Square Capital Management, an estimated $263M sold.
Based on aggregated 13F filings for Q1 2017.